- Moneycontrol /
- Market /
- Pharmaceuticals /
- NINE MONTHLY RESULTS
BSE Live
Mar 27, 16:00Prev. Close
136.30
Open Price
143.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Mar 27, 15:59Prev. Close
141.00
Open Price
148.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
133.95 (4726)
| Nine Months Results of Nath Bio-Genes (in Rs. Cr.) | Dec '19 | Dec '18 | Dec '17 | Dec '16 | Dec '15 | |
| Net Sales/Income from operations | 219.74 | 178.62 | 141.64 | 118.96 | 133.81 | |
| Other Operating Income | 1.33 | 1.85 | 0.13 | -- | -- | |
| Total Income From Operations | 221.08 | 180.47 | 141.77 | 118.96 | 133.81 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 109.87 | 83.47 | 43.18 | 55.94 | 67.50 | |
| Purchase of Traded Goods | 4.00 | 2.66 | 1.63 | -- | -- | |
| Increase/Decrease in Stocks | -18.46 | -8.88 | 19.49 | -6.32 | -17.93 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 12.52 | 15.52 | 11.74 | 11.66 | 11.50 | |
| Depreciation | 1.10 | 1.05 | 0.75 | 2.63 | 3.91 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | 48.04 | 32.93 | 22.55 | 25.40 | 38.08 | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 15.81 | 14.48 | 6.30 | 4.19 | 7.44 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 48.19 | 39.25 | 36.12 | 25.45 | 23.30 | |
| Other Income | -- | -- | -- | 0.36 | 0.24 | |
| P/L Before Int., Excpt. Items & Tax | 48.19 | 39.25 | 36.12 | 25.81 | 23.55 | |
| Interest | 4.85 | 4.86 | 8.26 | 6.74 | 5.57 | |
| P/L Before Exceptional Items & Tax | 43.34 | 34.39 | 27.87 | 19.07 | 17.97 | |
| Exceptional Items | -- | -- | 0.14 | -- | -- | |
| P/L Before Tax | 43.34 | 34.39 | 28.00 | 19.07 | 17.97 | |
| Tax | 0.48 | 1.27 | 0.33 | 0.60 | 0.20 | |
| P/L After Tax from Ordinary Activities | 42.85 | 33.12 | 27.68 | 18.47 | 17.77 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | 0.00 | -0.02 | |
| Net Profit/(Loss) For the Period | 42.85 | 33.12 | 27.68 | 18.47 | 17.76 | |
| Equity Share Capital | 19.00 | 19.00 | 16.00 | 16.00 | 16.00 | |
| Reserves Excluding Revaluation Reserves | 531.43 | 483.35 | 149.26 | 123.77 | 108.89 | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 22.55 | 17.43 | 17.29 | 11.54 | 11.10 | |
| Diluted EPS | 22.55 | 17.43 | 17.29 | 11.54 | 11.10 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 22.55 | 17.43 | 17.29 | 11.54 | 11.10 | |
| Diluted EPS. | 22.55 | 17.43 | 17.29 | 11.54 | 11.10 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | 0.78 | 0.88 | |
| Share Holding (%) | -- | -- | -- | 48.72 | 54.99 | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | 0.64 | 0.44 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | 78.17 | 61.36 | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | 40.09 | 27.62 | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | 0.18 | 0.28 | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | 21.83 | 38.64 | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | 11.19 | 17.39 |
31.01.2020
Nath Bio-Genes Standalone December 2019 Net Sales at Rs 33.44 crore, up 18.31% Y-o-Y
05.08.2019
Nath Bio-Genes Standalone June 2019 Net Sales at Rs 165.95 crore, up 30.04% Y-o-Y
30.05.2019
Nath Bio-Genes Standalone March 2019 Net Sales at Rs 52.73 crore, up 3.75% Y-o-Y
04.02.2019
Nath Bio-Genes Standalone December 2018 Net Sales at Rs 28.26 crore, up 9.63% Y-o-Y
31.01.2020
Nath Bio-Genes Standalone December 2019 Net Sales at Rs 33.44 crore, up 18.31% Y-o-Y
05.08.2019
Nath Bio-Genes Standalone June 2019 Net Sales at Rs 165.95 crore, up 30.04% Y-o-Y
30.05.2019
Nath Bio-Genes Standalone March 2019 Net Sales at Rs 52.73 crore, up 3.75% Y-o-Y
04.02.2019
Nath Bio-Genes Standalone December 2018 Net Sales at Rs 28.26 crore, up 9.63% Y-o-Y
